The era of equity – or striving for it – is not about rewriting history. Nor is it about righting history’s myriad wrongs. History has happened. History is toast. History is, erm, history – in the ...

IRLAB Therapeutics AB has announced the successful completion of the first part of its Phase I clinical trial for IRL757, a drug candidate aimed at treating apathy in patients with Parkinson’s disease ...

AlzeCure Pharma AB, a company specializing in drugs for nervous system diseases, announced that its abstract on NeuroRestore ACD856 has been accepted for presentation at the Clinical Trials in ...

Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe The European Commission has approved Yuvanci (macitentan 10 mg and tadalafil 40 mg), a single tablet ...

In clinical research, leveraging patient data has become a critical factor to improve the design, execution and outcome of clinical trials. Collecting data is no longer enough; the true challenge lies ...

Sphere Fluidics has appointed Dr Alex Dickinson to its Board of Directors Sphere Fluidics has announced the appointment of Dr Alex Dickinson to its Board of Directors as a Non-Executive Director (NED) ...

Imagine a world where good is evil and evil is good, where heroes are villains and villains are heroes, where beauty and intelligence are reviled, where the sun is blood red instead of yellow, and ...

Pharma’s experience in honing the management of regulated product data and content presents some useful lessons for medical device suppliers as their own regulatory workloads increase. A steady ...

The number one purpose of packaging is to protect the product. Throughout the supply chain – from design and manufacture through to filling and shipping – this is the golden rule. And in the ...

Over the years we have seen significant updates to regulations and guidance across the medical devices, in vitro diagnostic and pharmaceutical sectors. It is clearly well recognised that through the ...

New government scheme to offer routine opt-out blood tests Starting next week, Sheffield’s Northern General Hospital A&E Department will begin routine opt-out testing for HIV, hepatitis B, and ...